|
1
|
Yang D, Yuan Y, Zhang S, Zhao K, Li F, Ren
H, Zhang Z and Yu Y: Association between IL-13 Gene rs20541
polymorphism and glioma susceptibility: A meta-analysis. Oncol Res
Treat. 41:14–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bas Ayata H, Ceylan C, Kilic A, Guden M
and Engin K: Comparison of multiple treatment planning techniques
for high-grade glioma tumors near to critical organs. Oncol Res
Treat. 41:514–519. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hua S, Li H, Liu Y, Zhang J, Cheng Y and
Dai C: High expression of GALNT7 promotes invasion and
proliferation of glioma cells. Oncol Lett. 16:6307–6314.
2018.PubMed/NCBI
|
|
4
|
Su C, Li H and Gao W: TRIM28 is
overexpressed in glioma and associated with tumor progression. Onco
Targets Ther. 11:6447–6458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai X, Deng Z, Guo H, Zhu X and Tu W: HP1α
is highly expressed in glioma cells and facilitates cell
proliferation and survival. Cancer Biomark. 20:453–460. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paul S: Integration of miRNA and mRNA
expression data for understanding etiology of gynecologic cancers.
Methods Mol Biol. 1912:323–338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S, Chen Y, Yu X, Lu Y, Wang H, Wu F
and Teng L: miR-129-5p attenuates cell proliferation and epithelial
mesenchymal transition via HMGB1 in gastric cancer. Pathol Res
Pract. 215:676–682. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang X, Liang M, Dittmar R and Wang L:
Extracellular microRNAs in urologic malignancies: Chances and
challenges. Int J Mol Sci. 14:14785–14799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JF, Zhang JS, Zhao ZH, Yang PB, Ji
SF, Li N, Shi QD, Tan J, Xu X, Xu CB and Zhao LY: MicroRNA-770
affects proliferation and cell cycle transition by directly
targeting CDK8 in glioma. Cancer Cell Int. 18:1952018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu GF, Geng F, Xiao Z, Chen YS, Han Y, You
CY, Gong NL, Xie ZM and Pan M: MicroRNA-6807-3p promotes the
tumorigenesis of glioma by targeting downstream DACH1. Brain Res.
1708:47–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian W, Wu W, Li X, Rui X and Wu Y:
MiRNA-139-3p inhibits the proliferation, invasion, and migration of
human glioma cells by targeting MDA-9/syntenin. Biochem Biophys Res
Commun. 508:295–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gulluoglu S, Tuysuz EC, Sahin M, Kuskucu
A, Kaan Yaltirik C, Ture U, Kucukkaraduman B, Akbar MW, Gure AO,
Bayrak OF and Dalan AB: Simultaneous miRNA and mRNA transcriptome
profiling of glioblastoma samples reveals a novel set of OncomiR
candidates and their target genes. Brain Res. 1700:199–210. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu J, Ye J, Zhang L, Xia L, Hu H, Jiang
H, Wan Z, Sheng F, Ma Y, Li W, et al: Differential expression of
circular RNAs in glioblastoma multiforme and its correlation with
prognosis. Transl Oncol. 10:271–279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong NW, Chen Y, Chen S and Wang X:
OncomiR: An online resource for exploring pan-cancer microRNA
dysregulation. Bioinformatics. 34:713–715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Q, Wang C, Hou Z, Wang G, Lv J, Wang
H, Yang J, Zhang Z and Zhang H: Serum microRNA-376 family as
diagnostic and prognostic markers in human gliomas. Cancer Biomark.
19:137–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Chen X, Sun L, Bi X, He H, Chen L
and Pang J: The function of MMP-28/TGF-β induced cell apoptosis in
human glioma cells. Exp Ther Med. 16:2867–2874. 2018.PubMed/NCBI
|
|
18
|
Xu L, Yu QW, Fang SQ, Zheng YK and Qi JC:
MiR-650 inhibits the progression of glioma by targeting FAM83F. Eur
Rev Med Pharmacol Sci. 22:8391–8398. 2018.PubMed/NCBI
|
|
19
|
Hu S, Xu L, Li L, Luo D, Zhao H, Li D and
Peng B: Overexpression of lncRNA PTENP1 suppresses glioma cell
proliferation and metastasis in vitro. Onco Targets Ther.
12:147–156. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie C, Xu M, Lu D, Zhang W, Wang L, Wang
H, Li J, Ren F and Wang C: Candidate genes and microRNAs for glioma
pathogenesis and prognosis based on gene expression profiles. Mol
Med Rep. 18:2715–2723. 2018.PubMed/NCBI
|
|
21
|
Long T, Liu Z, Zhou X, Yu S, Tian H and
Bao Y: Identification of differentially expressed genes and
enriched pathways in lung cancer using bioinformatics analysis. Mol
Med Rep. 19:2029–2040. 2019.PubMed/NCBI
|
|
22
|
Rahman MR, Islam T, Gov E, Turanli B,
Gulfidan G, Shahjaman M, Banu NA, Mollah MNH, Arga KY and Moni MA:
Identification of prognostic biomarker signatures and candidate
drugs in colorectal cancer: Insights from systems biology Analysis.
Medicina (Kaunas). 55(pii): E202019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Liu Y, Li L, Xu Z, Bi B, Wang Y and
Li JY: MiR-7-5p is frequently downregulated in glioblastoma
microvasculature and inhibits vascular endothelial cell
proliferation by targeting RAF1. Tumour Biol. 35:10177–10184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Qiu M, An Y, Huang J and Gong C:
miR-7-5p acts as a tumor suppressor in bladder cancer by regulating
the hedgehog pathway factor Gli3. Biochem Biophys Res Commun.
503:2101–2107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Block I, Burton M, Sorensen KP, Andersen
L, Larsen MJ, Bak M, Cold S, Thomassen M, Tan Q and Kruse TA:
Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with
recurrence in systemically untreated breast cancer. Oncotarget.
9:9030–9042. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giles KM, Brown RA, Epis MR, Kalinowski FC
and Leedman PJ: miRNA-7-5p inhibits melanoma cell migration and
invasion. Biochem Biophys Res Commun. 430:706–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tseng HH, Tseng YK, You JJ, Kang BH, Wang
TH, Yang CM, Chen HC, Liou HH, Liu PF, Ger LP and Tsai KW:
Next-generation sequencing for microRNA profiling: MicroRNA-21-3p
promotes oral cancer metastasis. Anticancer Res. 37:1059–1066.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li SJ, Zhou J, Zhang L, Xiang W, Hu Q, He
YY and Chen LG: The effect of miR-21 on SWOZ2 glioma cells and its
biological mechanism. J BUON. 22:468–473. 2017.PubMed/NCBI
|
|
29
|
Ujifuku K, Mitsutake N, Takakura S,
Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K,
Nagata I and Yamashita S: miR-195, miR-455-3p and miR-10a(*) are
implicated in acquired temozolomide resistance in glioblastoma
multiforme cells. Cancer Lett. 296:241–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizoguchi M, Guan Y, Yoshimoto K, Hata N,
Amano T, Nakamizo A and Sasaki T: Clinical implications of
microRNAs in human glioblastoma. Front Oncol. 3:192013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Dutta A and Abounader R: The role
of microRNAs in glioma initiation and progression. Front Biosci
(Landmark Ed). 17:700–712. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han J, Xiong Y, Deng H, Zhou J, Peng L,
Xiang W, Ming Y and Chen L: MiR-455-3p regulates glioma cell
proliferation by targeting PAX6. Tropical J Pharmaceutical Res.
18:689–695. 2019.
|
|
33
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Zhao W, Ge C, Li X, Yang X, Xiang
Y and Sun Z: Decreased let-7b is associated with poor prognosis in
glioma. Medicine (Baltimore). 98:e157842019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo J, Liu C, Wang W, Liu Y, He H, Chen C,
Xiang R and Luo Y: Identification of serum miR-1915-3p and
miR-455-3p as biomarkers for breast cancer. PLoS One.
13:e02007162018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR,
Ding Y, Liang JQ, Li TT and Zhao J: MiR-497-5p, miR-195-5p and
miR-455-3p function as tumor suppressors by targeting hTERT in
melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao X, Zhao H, Diao C, Wang X, Xie Y, Liu
Y, Han J and Zhang M: miR-455-3p serves as prognostic factor and
regulates the proliferation and migration of non-small cell lung
cancer through targeting HOXB5. Biochem Biophys Res Commun.
495:1074–1080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang H, Wei YN, Zhou J, Hao TT and Liu XL:
MiR-455-3p acts as a prognostic marker and inhibits the
proliferation and invasion of esophageal squamous cell carcinoma by
targeting FAM83F. Eur Rev Med Pharmacol Sci. 21:3200–3206.
2017.PubMed/NCBI
|
|
39
|
Chen H, Judkins J, Thomas C, Wu M, Khoury
L, Benjamin CG, Pacione D, Golfinos JG, Kumthekar P, Ghamsari F, et
al: Mutant IDH1 and seizures in patients with glioma. Neurology.
88:1805–1813. 2017. View Article : Google Scholar : PubMed/NCBI
|
